These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Weiss JN; Bynoe LA Ophthalmology; 2001 Dec; 108(12):2249-57. PubMed ID: 11733266 [TBL] [Abstract][Full Text] [Related]
3. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Weiss JN Am J Ophthalmol; 1998 Jul; 126(1):142-4. PubMed ID: 9683166 [TBL] [Abstract][Full Text] [Related]
4. Sequential treatment of central retinal vein occlusion with intravitreal tissue plasminogen activator and intravitreal triamcinolone. Lahey JM; Kearney JJ; Cheung MC Br J Ophthalmol; 2004 Aug; 88(8):1100-1. PubMed ID: 15258039 [No Abstract] [Full Text] [Related]
5. Surgical treatment of central retinal vein occlusion. Berker N; Batman C Acta Ophthalmol; 2008 May; 86(3):245-52. PubMed ID: 18494725 [TBL] [Abstract][Full Text] [Related]
6. Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Hattenbach LO; Wellermann G; Steinkamp GW; Scharrer I; Koch FH; Ohrloff C Ophthalmologica; 1999; 213(6):360-6. PubMed ID: 10567867 [TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy. Collen D Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986 [No Abstract] [Full Text] [Related]
8. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion. Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C Retina; 2009; 29(7):932-40. PubMed ID: 19584651 [TBL] [Abstract][Full Text] [Related]
9. Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion. Chen CS; Lee AW; Campbell B; Paine M; Lee T; Fraser C; Grigg J; Markus R; Williams K; Coster DJ Int J Stroke; 2011 Feb; 6(1):87-9. PubMed ID: 21205247 [TBL] [Abstract][Full Text] [Related]
10. Intravenous tissue plasminogen activator for acute stroke in California: recipients and resources. Birbeck GL; Cui X; Zingmond DS; Vickrey BG Cerebrovasc Dis; 2004; 17(4):341-3. PubMed ID: 15103183 [No Abstract] [Full Text] [Related]